According to the website of the National Health Commission, in order to further optimize the testing strategy for the novel coronavirus and based on the needs of epidemic prevention and control, the Comprehensive Group of the State Council’s Joint Prevention and Control Mechanism has decided to promote a monitoring model of “antigen screening and nucleic acid diagnosis,” adding antigen testing as a supplement to nucleic acid testing. Recently, the Comprehensive Group formulated and issued the “Application Plan for Novel Coronavirus Antigen Testing (Trial),” requiring all regions to carefully organize and implement it.
As of now, five COVID-19 antigen self-test products have been approved for market launch in China, developed by Nanjing Vazyme, Beijing Jinwoof, Shenzhen BGI Genomics, Guangzhou Wondfo Biotech, and Beijing Huake Tai Biotechnology.
It is reported that Baidu Health has partnered with multiple approved manufacturers and their distributors. Currently, COVID-19 antigen test kits have been listed for sale first. Users can purchase these kits for self-testing by searching for the Baidu Health mini-program via the Baidu App and then searching for “COVID-19 Antigen Test” in the Baidu Health Mall.
Antigen test kits can be used in a home setting, with results typically available within 15–20 minutes. They eliminate the need to visit a hospital, thereby avoiding steps such as queuing, registration, and waiting for test results, offering convenience and efficiency.